5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Gerber F, Krafft MP, Vandamme TF, Goldmann M, Fontaine P. Potential use of fluorocarbons in lung surfactant therapy. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 35: 211-20. PMID 17453705 DOI: 10.1080/10731190601188307  0.32
2007 Gerber F, Waton G, Krafft MP, Vandamme TF. Long lived microbubbles for oxygen delivery. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 35: 119-24. PMID 17364476 DOI: 10.1080/10731190600974939  0.32
2007 Gerber F, Krafft MP, Vandamme TF. The detrimental effect of serum albumin on the re-spreading of a dipalmitoyl phosphatidylcholine Langmuir monolayer is counteracted by a fluorocarbon gas. Biochimica Et Biophysica Acta. 1768: 490-4. PMID 17097604 DOI: 10.1016/j.bbamem.2006.09.022  0.32
2006 Gerber F, Krafft MP, Vandamme TF, Goldmann M, Fontaine P. Fluidization of a dipalmitoyl phosphatidylcholine monolayer by fluorocarbon gases: potential use in lung surfactant therapy. Biophysical Journal. 90: 3184-92. PMID 16500985 DOI: 10.1529/biophysj.105.077008  0.32
2005 Gerber F, Krafft MP, Vandamme TF, Goldmann M, Fontaine P. Preventing crystallization of phospholipids in monolayers: a new approach to lung-surfactant therapy. Angewandte Chemie (International Ed. in English). 44: 2749-52. PMID 15849691 DOI: 10.1002/anie.200462978  0.32
Show low-probability matches.